Medicare to Negotiate Lower Prices for Weight-Loss Drugs
The government is expected to pay lower prices for Ozempic and Wegovy starting in 2027. The Trump administration will decide whether to expand coverage for millions of Americans.
Trump to lead Medicare drug negotiations
Now, Mr. Trump can build upon the provision in the Inflation Reduction Act that allows Medicare to negotiate prices on certain drugs. By pushing for tougher agreements with pharma
Ozempic, Ibrance among next drugs picked by Medicare for price talks
Announcing the 15 medicines chosen for the second round of negotiations is one of the Biden administration’s final health policy acts.
Ozempic and Wegovy among drugs on Medicare list getting price cuts
The US plans to slash the price it pays for the Novo Nordisk A/S blockbusters Ozempic and Wegovy, the latest drugs to be targeted under legislation that’s expected save the government more than $200 billion over a decade.
Ozempic and Wegovy selected for next round of Medicare drug price negotiations
Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will be subject to<a class="excerpt-read-more" href=" More
Medicare targets popular weight loss drugs Ozempic, Wegovy for price negotiations
The Biden administration said Medicare will negotiate discounts with drug companies on 15 drugs prescribed to treat cancer, diabetes and asthma.
Explainer: What Wegovy's inclusion in Medicare price negotiation means for patients, company
The U.S. government on Friday announced a list of 15 prescription medicines targeted for Medicare price negotiations for 2027, which includes Novo Nordisk's blockbuster weight-loss drug Wegovy. Here's
Ozempic among drugs targeted in upcoming Medicare price negotiations
Novo Nordisk’s blockbuster diabetes and weight-loss drugs Ozempic and Wegovy are among a group of 15 drugs set to be affected by the next round of US government price negotiations by Medicare. The group of drugs accounted for about $41bn in annual spending by Medicare,
Musk, Ramaswamy ready to go to war with seniors. Trump won't save Social Security. | Letters
Letters: Musk, Ramaswamy will declare war on seniors. Developing good citizens is the key to our future. Democrats should ...
Donald Trump and Social Security: 10 Things You Need to Know
Like most elected officials, Donald Trump recognizes that Social Security is vital to the financial well-being of our ...
What Is Agenda47? What To Know About Trump’s Policy Agenda Before His Inauguration
Education: Trump’s proposals for K-12 schools include having parents elect school principals, cutting federal funding to any ...
Investor's Business Daily on MSN17h
Here's How Donald Trump Could Shake Up Health Care — And Biotech Stocks
Biotech stocks have slumped 15% since Donald Trump won his second presidency. That's because Trump comes with a lot of ...
Biden Adds Ozempic to Medicare Price Renegotiation Talks
Biden's administration announced weight loss drugs Ozempic and Wegovy will be included on Medicare's list of medications subject to direct price negotiations.
Johnson says no cuts to Social Security and Medicare to fund Trump's agenda
House Speaker Mike Johnson said cuts to Social Security and Medicare won't be part of the legislative plan being worked out ...
Medicare and telehealth: more restrictive rules could hit patients in 2025
Instead, people on Medicare won’t get the two years of continued coverage for telehealth appointments and five years’ for ...
The Telegraph6h
CBO projects US debt to grow $23.9 trillion in 10 years, not including costs of extending tax cuts
The national debt is slated to rise by $23.9 trillion over the next decade, a sum that does not include trillions of dollars ...